0001179110-19-010493.txt : 20190919
0001179110-19-010493.hdr.sgml : 20190919
20190919162918
ACCESSION NUMBER: 0001179110-19-010493
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190918
FILED AS OF DATE: 20190919
DATE AS OF CHANGE: 20190919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Komjathy Andrew
CENTRAL INDEX KEY: 0001788465
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 191102019
MAIL ADDRESS:
STREET 1: CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-09-18
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001788465
Komjathy Andrew
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ, BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
5.92
2019-09-18
4
A
0
44500
0
A
2029-09-17
Common Stock
44500
44500
D
This option was granted on September 18, 2019 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 18, 2019 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Deirdre A. Cunnane, as Attorney-in-fact for Andrew Komjathy
2019-09-19